inDNA

Pune, India Founded: 2013 • Age: 13 yrs
Delivers comprehensive genomic analysis solutions for routine clinical care.
Annual revenue $28 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About inDNA

inDNA is a company based in Pune (India) founded in 2013 by Alka Aditya Phatak and Aditya Deepak Phatak. It operates as a B2B. inDNA operates in a competitive market with competitors including GRAIL, Denali Therapeutics, Poseida Therapeutics, Castle Biosciences and Color, among others.

  • Headquarter Pune, India
  • Founders Alka Aditya Phatak, Aditya Deepak Phatak
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Indna Research Labs Private Limited
  • Date of Incorporation 10 Apr, 2013
  • Jurisdiction Pune, Maharashtra, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $28.18 (USD)
    0
    as on Mar 31, 2017
  • Net Profit
    $2.18 K (USD)
    0
    as on Mar 31, 2017
  • EBITDA
    -$1.46 K (USD)
    0
    as on Mar 31, 2017
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of inDNA

Premium access

Detailed funding history for inDNA

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by inDNA

Investments
Premium access

Investment portfolio details for inDNA

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - inDNA

Premium access

Detailed financials for inDNA

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Indna Comparisons

inDNA Primary company
Description
Delivers comprehensive genomic analysis solutions for routin...
Location
Pune, India
Founded Year
2013
Annual Revenue
$28.18 (USD)
Net Profit
$2.18 K (USD)
EBITDA
-$1.46 K (USD)
Employees
Not available
Premium access

Peer comparison for inDNA

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of inDNA

inDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Denali Therapeutics, Poseida Therapeutics, Castle Biosciences and Color, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Circulating tumor DNA is screened for early cancer detection.
Locked Locked Locked
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
Locked Locked Locked
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
Locked Locked Locked
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
Locked Locked Locked
Cancer care is delivered through a virtual clinic by Color.
Locked Locked Locked
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
Premium access

Detailed competitors of inDNA

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Indna

Premium access

Complete news archive for inDNA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about inDNA

inDNA was founded in 2013.

inDNA is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Aditya Deepak Phatak is the current CEO of inDNA. They have also founded this company.

Annual revenue of inDNA is $28.18 as on Mar 31, 2017.

inDNA, led by Alka Aditya Phatak as Co-Founder, Aditya Deepak Phatak as Founder, CEO, specializes in providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and clinical analysis. Delivers comprehensive genomic analysis solutions for routine clinical care. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

inDNA's top competitors include GRAIL, Juno Therapeutics and Poseida Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available